News

As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...
Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type ...
Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily ...
Recently, tennis legend Serena Williams opened up about using weight-loss medication, aiming to break the ‘stigma’ around ...
Participants on the 36 mg oral dose drop 12.4% of their body weight at 72 weeks, yet physicians warn of posttreatment weight ...
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry that they’ll ...
Cipla shares are in demand on Dalal Street amid market buzz that it is in talks with Eli Lilly for the Semaglutide drug.
A relatively old drug -- metformin -- may hold the key to preventing life-threatening illness and bolstering human longevity, ...
As appetite-suppressing drugs change the way people eat, businesses are adapting to GLP-1 users by offering smaller portions ...
The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline ...
Scientists at Jiangnan University in China recently found that there is a specific gut microbe known as Bacteroides vulgatus, ...